Publications

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.

CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;

2023

The Lancet. Global health, (2023).11 4 10.1016/S2214-109X(23)00045-1.

Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study.

SBARRA, AN; Mosser, JF; JIT, M; Ferrari, M; Ramshaw, RE; O'Connor, P; Krause, LK; Rogowski, EL B; Portnoy, A;

2023

The Lancet. Global health, (2023).11 4 10.1016/S2214-109X(23)00043-8.

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.

KOLTAI, M; Moyes, J; Nyawanda, B; Nyiro, J; Munywoki, PK; Tempia, S; Li, X; Antillon, M; Bilcke, J; FLASCHE, S; Beutels, P; Nokes, DJ; Cohen, C; JIT, M;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02806-w.

Adeno-associated virus 2 infection in children with non-A-E hepatitis.

Ho, A; Orton, R; Tayler, R; Asamaphan, P; Herder, V; Davis, C; Tong, L; Smollett, K; Manali, M; Allan, J; Rawlik, K; McDonald, SE; Vink, E; Pollock, L; Gannon, L; Evans, C; McMenamin, J; Roy, K; Marsh, K; Divala, T; Holden, MT G; Lockhart, M; Yirrell, D; Currie, S; O'Leary, M; ... Thomson, EC.

2023

Nature, (2023).617 7961 10.1038/s41586-023-05948-2.

Genomic investigations of unexplained acute hepatitis in children.

Morfopoulou, S; Buddle, S; Torres Montaguth, OE; Atkinson, L; Guerra-Assunção, JA; Moradi Marjaneh, M; Zennezini Chiozzi, R; Storey, N; Campos, L; Hutchinson, JC; Counsell, JR; Pollara, G; Roy, S; Venturini, C; Antinao Diaz, JF; Siam, A; Tappouni, LJ; Asgarian, Z; Ng, J; Hanlon, KS; Lennon, A; McArdle, A; Czap, A; Rosenheim, J; Andrade, C; ... Breuer, J.

2023

Nature, (2023).617 7961 10.1038/s41586-023-06003-w.

Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models.

Giddings, R; INDRAVUDH, P; MEDLEY, GF; BOZZANI, F; GAFOS, M; Malhotra, S; TERRIS-PRESTHOLT, F; TORRES-RUEDA, S; Quaife, M;

2023

PharmacoEconomics, (2023).41 6 10.1007/s40273-023-01260-z.

The stated preferences of community-based volunteers for roles in the prevention of violence against women and girls in Ghana: A discrete choice analysis.

ARORA, N; Dit Sourd, RC; Quaife, M; VASSALL, A; Ferrari, G; Alangea, DO; Tawiah, T; Dwommoh Prah, RK; Jewkes, R; HANSON, K; TORRES RUEDA, S;

2023

Social science & medicine, (2023).324, 10.1016/j.socscimed.2023.115870.

Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study.

WATERLOW, NR; Radhakrishnan, S; Dawa, J; VAN LEEUWEN, E; PROCTER, SR; Lambach, P; Bresee, J; Mazur, M; EGGO, RM; JIT, M;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02830-w.

What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria.

RUIZ, FJ; TORRES-RUEDA, S; PEARSON, CA B; Bergren, E; Okeke, C; PROCTER, SR; Madriz-Montero, A; JIT, M; VASSALL, A; Uzochukwu, BS C;

2023

PLOS global public health, (2023).3 3 10.1371/journal.pgph.0001693.

Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy.

WIEDMANN, L; CAIRNS, J;

2023

Expert review of pharmacoeconomics & outcomes research, (2023).23 5 10.1080/14737167.2023.2193690.